Clinical trial
The ARDS, Pneumonia, and Sepsis (APS) Consortium: A Prospective Observational Study to Evaluate Phenotypes
NCT06521502 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The ARDS, Pneumonia, and Sepsis (APS) Consortium: A Prospective Observational Study to Evaluate Phenotypes
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 25, 2024
- Completion date
- April 30, 2029
- Enrollment
- 4,000 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.